Photodynamic Therapy Market Report by Product Types (Photodynamic Therapy Devices, Photosensitizer Drugs), Application (Cancer, Actinic Keratosis, Psoriasis, Acne, Others), End-User (Hospitals, Cosmetics & Dermatology Clinics, Cancer Treatment Centers, Others), Countries and Company Analysis 2024- 2032
Buy NowGlobal Photodynamic Therapy Market Size
Photodynamic Therapy Market is projected to reach US$ 6.97 Billion by 2032 from US$ 3.63 Billion in 2023. According to Renub Research, it's predicted to expend at a CAGR of 7.52% from 2024 to 2032
Photodynamic remedy is an antitumor treatment method that uses photosensitizers in various tumors. PDT relies on administering a mild sensitive dye to the target site accompanied by excitation with light of appropriate wavelength and fluence. This photo-activated molecule reacts with intracellular oxygen to induce selective cytotoxicity of centered cells by generating reactive oxygen species.
| Report Features | Details |
|
Base Year |
2023 |
|
Forecast Years |
2024 - 2032 |
|
Historical Years |
2019 - 2023 |
|
Market Size in 2023 |
US$ 3.63 Billion |
|
Market Forecast in 2032 |
US$ 6.97 Billion |
|
Market Growth Rate (2024-2032) |
7.52% |
Growth Driver of the Photodynamic Therapy Market
The global incidence of skin cancers is on the rise, and this is fueling more demand for additional therapies like photodynamic therapy.
Globally, the occurrence of cancer has been on the rise, especially skin cancer, hence stepping up the need for complementary therapies such as PDT. This new method uses light and photosensitizing agents that selectively attack the cancer cells. It could be an added treatment to traditional treatments, including chemotherapy, surgery, and radiation therapy. The ability of photodynamic therapy to be a superficial treatment and the capacity to attack particular cells give PDT a definite advantage in skin cancer and several other kinds of cancer. When people become aware of photodynamic therapy coupled with medical developmental breakthroughs, the specificity of photodynamic therapy will replace traditional treatments with minimal side effects but high outcomes. This trend aligns with current progress in treating the disease, where multimodal therapies and novel innovations have significant roles in cancer management, reducing worldwide disease burden.
Technological developments: The trends in the development of the light source, photosensitizer, and drug delivery system play a central role in increasing the effectiveness of Photodynamic Therapy (PDT) accuracy and ease of use, thus contributing to the market's growth. New technologies that have become available include the ability to aim better the light developed for cancers and photosensitizers that help to increase the therapeutic ratio. Also, the side effects of the treatment are minimized. Also, advancements in delivery systems make it possible to deliver light and photosensitizing agents very efficiently, enhancing the overall effectiveness of the treatment. Such technological improvements in PDT extend its use in various types of cancers and improve the comfort of the patients and the efficiency of the treatment. Thus, PDT is gradually considered an essential element of effective therapy in oncology, determining its demand and the further spread of its use in various countries. More studies and innovations are anticipated to create higher growth for PDT because of better results and the expansion of the potential usage of PDT in cancer therapies.
Growing public awareness: The benefits and usage of photodynamic therapy are already gaining the public's attention. This is a therapy where light, besides a photosensitizing agent, is used to destroy cancerous cells specifically. It is increasingly being recommended for use due to its efficiency against various kinds of cancer, such as skin cancer. With the growth of awareness concerning the non-exposure of its dangerous side and capacity to reduce side effects compared to other conventional treatments such as surgery and chemotherapy, interest in photodynamic therapy persists. This has led to the patients requesting it in their treatment procedures due to the awareness, which in turn is making healthcare providers and researchers seek it and develop more uses for it. Thus, people witness a constant development of practical approaches based on photodynamic therapy, proven by positive patient outcomes that make PDT one of the valuable options in cancer treatment.
The demand for complementary treatment like photodynamic therapy is rising due to the upward thrust in cancer rate, particularly skin cancer
The demand for complementary treatment, particularly photodynamic therapy, has increased due to the growing prevalence of cancer worldwide. This opportunity treatment is gaining popularity as many human beings use it to manage their conditions. The growth of the photodynamic therapy marketplace is pushed through elevated consumer knowledge, growing R&D, and growing treatments for various conditions. Additionally, the demand for photosensitizer therapies and equipment used in treating cancers is expected to propel the boom of the photodynamic therapy market. Cancer is one of the substantial reasons of loss of life globally, accounting for more than 10 million deaths in 2020, and demand for photosensitizer therapies is expected to increase due to the growing cancers cases international. Actinic keratosis is a skin precancer more often delivered on via extended, unprotected exposure to UV mild, and its increasing occurrence is expected to enhance the demand for photodynamic remedy for its treatment and care.
PDT therapy is gaining popularity as people analyze more approximately its advantages and uses
Photodynamic therapies is a scientific procedure that makes use of mild and photosensitizing chemical compounds to deal with cancer and skin problems. The demand for PDT treatment is rising because of its effectiveness, low invasiveness, and capacity benefits over traditional cures. The increasing cognizance of photodynamic therapy's benefits is found to behave as a motive force for the worldwide market. This growing consciousness is raising interest from academic, investors, and healthcare specialists and growing patients acceptance rates. PubMed study performed in 2019 revealed that 86.2% of Chinese sufferers with oral leukoplakia answered definitely to photodynamic remedy. The study confirmed complete remission in 55.2% of instances and partial remission in 31.0%.
United States PDT Therapy Market
The United States market for photodynamic treatment devices is predicted to grow profitably because of improved R&D spending, technological traits, and public consciousness of the treatment. The upward push in cancer cases and the expanding use of photodynamic therapy as a treatment are also predicted to contribute to the enlargement of the marketplace. The National Board of Health and Welfare said that during 2020, the USA Cancer Registry received reviews of 68,318 malignant tumors from 62,555 individuals. PDT is a less invasive treatment that minimizes damage to healthful tissues, enhancing patient’s quality of life. Its financial advantages and tailored approach are driving the Photodynamic Therapy marketplace revenue notwithstanding the quantity of cancer-associated deaths being higher than the number of humans recognized with the disease.
In January 2023, Biofrontera Bioscience GmbH received a notice of allowance from USA Patent Office for a patent application on a novel lights method for Photodynamic Therapy (PDT) treatment of skin issues.
Biofrontera Inc.'s BF-RhodoLED XL has achieved a considerable milestone through being indexed inside the FDA's Orange Book. This reputation via the FDA, coupled with the tool's previous patent in the US in March 2022 under patent range 11,235,169, validates the devices protection and efficacy, bolstering investor confidence inside the photodynamic treatment devices marketplace.
Europe Photodynamic Therapy Market
PDT is a rapidly growing medical sector in Europe and especially in France and Germany as a result of enhanced technology development and new applications in oncology as well as dermatology. PDT is an ABI technique that uses a photosensitizer and light to address diseased cells without affecting the surrounding healthy tissue, which makes PDT a relatively non-invasive approach in comparison with common treatments.
The photodynamic therapy market is growing in France because France possess a sound healthcare system now and is adopting innovative treatments. The French hospitals and research organizations are the most advance in the use of PDT for different indications such as skin malignancies and ocular diseases. An increasing penetration of medical technologies in France, especially those supported by the government, is a crucial factor behind the growth of the market together with the constant awareness of healthcare establishments in the effectiveness of PDT.
Germany is also among the countries that are steadily growing the PDT market mainly because of its elaborate medical R&D facilities. The health care system of the country is popular for its focus towards adoption of latest technologies in clinical procedures. German PDT researchers continue to define new areas of PDT application and optimize current methods, increasing the efficacy and the safety of the treatments. Also, the rules and policies in Germany for the medical technology innovation are compelling and favorable for PDT.
Middle East Photodynamic Therapy Market
The growth of photodynamic therapy (PDT) market in Saudi Arabia and UAE of the Middle East is seen due to technological enhancement, innovative treatments for cancer and skin disease. PDT, a minimally invasive procedure that entails using light-sensitive drugs and light on the targeted abnormal cells, is gradually picking up in the zone as health facilities are enhanced and as the population becomes awer to advanced treatments.
Many advanced treatments made Saudis invest in modernizing health care facilities and increased the accessibility of such treatments gave a boost to PDT. In Saudi Arabia, PDT has being adopted in Hospitals and clinics as part of its therapeutic tools, especially for control of skin cancer and ophthalmological diseases. PDT’s in the country are driven by the government’s efforts to improve healthcare services and increased incidence of cancer and skin related diseases.
PDT’s market is also rapidly growing in the UAE because of the developed healthcare system and the emphasis on medical advances. Due to the UAE’s current focus on the use of new technologies in healthcare, such as medical technologies, the use of PDT is used for oncology and dermatology. The availability of sophisticated health care facilities and new researches on the photodynamic therapy are catalyzing the growth of the market. Also, the UAE possesses a strategic importance in delivering state of art treatments for PDT and draws a significant number of international patients due to its status of being a health care destination in the region.
Global Photodynamic Therapy Company Analysis
Several competitors, which include Gladerma S.A., Sun Pharmaceutical Industries Ltd., Biofrontera Inc., Lumibird S.A., Bausch Health Companies Inc., Soligenix Inc., Modulight Corporation, and Theralase Technologies Inc lead the photodynamic therapy Industry.
Global Photodynamic Therapy Company New
- Jan 2024 - Metallopolymer strategy to explore hypoxic energetic slim-bandgap photosensitizers for powerful cancer photodynamic therapy
- In Jan 2023 - Biofrontera Bioscience GmbH granted a patent by the United States Patent and Trademark Office for a brand-new technique for treating skin conditions with Photodynamic Therapy (PDT).
- In February 2023 - the FDA accredited the ML6710i photodynamic laser for treating Age-related Macular Degeneration patients with conventional subfoveal choroidal neovascularization.
- In May 2023 - Rakuten Medical got approval from the Indian CDSCO to behavior a Phase III clinical trial on Alluminox treatment for patients with head and neck squamous cell carcinomas in India.
- In August 2023 - ImPact Biotech partnered with Maastricht University to research treating myopic macular degeneration the use of ImPact's Padeliporfin VTP platform.
According to a statement from the medicine's inventor, in July 2023, ImPact Biotech's product, which uses the photosensitizer padeliporfin and laser light delivery to treat locally advanced pancreatic cancer, has been granted orphan drug status by the FDA. It works by boosting antitumor immunity and intensifying cancer cell destruction.
- In February 2023 - The FDA gave Elranatamab's biologics license software top priority to deal with humans who have relapsed or refractory multiple myeloma (RRMM).
- In Sept 2022 - Quest PharmaTech Inc. sold its ownership interest in Bioceltran Co., Ltd. and returned its PDT technology license.
- In Jan 2021 - Olympus Corporation acquired Quest Photonic Devices B.V. to strengthen its surgical endoscopy abilities.
Product types – Market breakup in 2 viewpoints:
1. Photodynamic Therapy Devices
2. Photosensitizer Drugs
Application – Market breakup in 5 viewpoints:
1. Cancer
2. Actinic Keratosis
3. Psoriasis
4. Acne
5. Others
End-User – Market breakup in 4 viewpoints:
1. Hospitals
2. Cosmetics & Dermatology Clinics
3. Cancer Treatment Centers
4. Others
Country – Market breakup of 25 Countries:
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue Analysis
Company Analysis:
1. Gladerma S.A.
2. Sun Pharmaceutical Industries Ltd.
3. Biofrontera Inc.
4. Lumibird S.A.
5. Bausch Health Companies Inc.
6. Soligenix Inc.
7. Modulight Corporation
8. Theralase Technologies Inc.
Report Details:
| Report Features | Details |
| Base Year |
2023 |
| Historical Period |
2019 - 2023 |
| Forecast Period |
2024 - 2032 |
| Market |
US$ Billion |
| Segment Covered |
Product Type, Application, End User and Countries |
| Countries Covered |
|
| Companies Covered |
|
| Customization Scope |
20% Free Customization |
| Post-Sale Analyst Support |
1 Year (52 Weeks) |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Here are frequently asked questions (FAQs) in the Photodynamic Therapy (PDT) market:
• What is the current size of the Photodynamic Therapy (PDT) Market?
• What will the market size of the Photodynamic Therapy (PDT) Market be by 2032?
• What is Photodynamic Therapy?
• What are the benefits of PDT compared to traditional treatments?
• What are the side effects of PDT?
• Does insurance cover PDT?
• How effective is PDT in treating cancer?
• What advancements are being made in the PDT market?
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Photodynamic Therapy Market
6. Global Photodynamic Therapy – Market Share Analysis
6.1 By Product Type
6.2 By Application
6.3 By End User
6.4 By Countries
7. Product Type – Global Photodynamic Therapy Market
7.1 Photodynamic Therapy Devices
7.2 Photosensitizer Drugs
8. Application – Global Photodynamic Therapy Market
8.1 Cancer
8.2 Actinic Keratosis
8.3 Psoriasis
8.4 Acne
8.5 Others
9. End User – Global Photodynamic Therapy Market
9.1 Hospitals
9.2 Cosmetics & Dermatology Clinics
9.3 Cancer Treatment Centers
9.4 Others
10. Countries – Global Photodynamic Therapy Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherland
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa
11. Porter’s Five Forces Analysis – Global Photodynamic Therapy Market
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis – Global Photodynamic Therapy Market
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Key Players Analysis
13.1 Gladerma S.A
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue Analysis
13.2 Sun Pharmaceutical Industries Ltd
13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue Analysis
13.3 Biofrontera Inc.
13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue Analysis
13.4 Lumibird S.A
13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue Analysis
13.5 Bausch Health Companies Inc.
13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue Analysis
13.6 Soligenix Inc.
13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue Analysis
13.7 Modulight Corporation
13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue Analysis
13.8 Theralase Technologies Inc.
13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue Analysis
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com